Osimertinib, Third-generation irreversible EGFR-TKI, Treats EGFR-mutated non-small cell lung cancer, Effective against EGFR Ex19Del and EGFR L858R mutations, Central nervous system metastasis resistance,
Sale!
Lucius
Replica: Osimertinib Targeted EGFR Therapy for Lung Cancer
Original price was: $648.00.$489.00Current price is: $489.00.
Osimertinib, Third-generation irreversible EGFR-TKI, Treats EGFR-mutated non-small cell lung cancer, Effective against EGFR Ex19Del and EGFR L858R mutations, Central nervous system metastasis resistance,